Recent literature on fibrinolysis

Recent Literature on Fibrinolysis Enhancement of the fibrinolytic

activity in lasma by oral administration of nattokinase. Sumr Hp ; Hamada H: Nakanishi K; Hiratani H. Acta Haematol (Basel) 1990,84 (3) p139-43 [The characteristics of the blood anticoagulation sys*m and of urinary fibrin01 is in healthy newborn infants]. Gsobenosti na protivosuairv 2 tata sistema na kruvta i fibrinoloixa na urinata pri xdravi novorodeni detsa. Sams gina GA: Vykhristiuk OF. Akush Qinekol (Soiiia) 1990.29 (B) p3 l-7 The fibrinolytic system of the vessel wall and its role in the control of duombosis. Loskutoff DJ; Cuniden SA. Ann N Y Acad Sci 1990,598 ~238-47 Decreased fibrinolytic activity in juvenile chronic arthritis. Mussoni L; Pintucci G; Roman0 G, De Benedetti P; Massa M; Martini A. Ann Rhcum Dia Dee 1990.49 (12) 973-5 Dietary regulation of fibrinolytic factors. rKehrabian M, Peter JB; Barnard RI; Lusis AJ. Atherosclerosis Se-p 1990,84 (1) ~25-32 Mechanism of action of the thrombolytic agents. Weitz JI. Baillieres Clin Haematol Jul 1990,3 (3) p583-99 [Hemostasis, fibrinolysis, proteolysis: interaction with inflammatory reactions]. Hamostase, Fibrinolyse, Proteolyse: Wechselwirkunuen mit Entxundunnsreaktionen. Romisch J: Schuler E; Pa&s Ep; HeimburgerN. B&ring Inst Mitt Get 1990, (86) p12945 [Process of fibrin &polymerization and non-enzymatic tibrinolysis in rabbits rece&gatherogenic rations witiaddition of _ antioxidants]. Protsess depolimerixatsii fibrina i nefermentativnyi fibrinoliz u krolikov, poluchaiushchikh aterogennyi ratsion s dobavkniem antioksidantov. Kudriashov BA: Pastorova VE, Liapina LA: Kondashevskaia Mv, Kobozeva LP. Biull Eksp Biol Med Get 1990,110 (IO) p41921 Enhancement of the Ebrinolytic activity of sheep endothelial cells by retroviral vector-mediated gene transfer. Dichek DA; Nussbaum 0; Degen SJ: Anderson WF. Blood Feb 1 1991.77 (3) p533-41 Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plssminogen activator inhibitor type-l, and fibrin(ogen) degradation products. van Hinsbergh VW: Bauer KA, Kooistra T; Kluft C; Dooijewaard G; Sherman ML: Nieuwenhuizen W. Blood Dee 1 1990,76 (11) p2284-9 Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: activation of blood coagulation, ftbrinol sis and unspecific proteolysis. Speiser W; Pabinger-Fasching f, Kyrle PA: Kaprotis S: Kottas-Heldenberg A ; Bcttelheim P; Lechner K. Blut Nov 1990,61(5) p298-302 A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator compkx, APSAC) in acute myocardial infarction. Brugemsnn J: van der Meer J; Takens BH; Hillege H; Lie KI. Br Heart J Dee 1990.64 (6) ~355-8 Do stone formers have lower urinary fibrinolytic activity than controls?. Margetts BM; Barker DJ; Kavaoagh JP: Blacklock NJ. Br J Urol Dee 1990,66 (6) ~581-4 Occurrence of components of fibrinolysis pathways in situ in neo lastic and nonneoplastic human breast tissue. Costantini V: Acharski LR; Memoli VA: Kudryk BJ; Rousseau SM: Stump DC. Cancer Res Jan 1 1991,51(l) ~354-8 The activation of plasminogen by tissue plasminogen activator is not enhanced by different heparin species as assessed in vitro with a solid-phase fibrin method. Grailhe P; Angles-Cano E. Fibrinolysis Apr 1991.5 (2) ~61-9 Effect of intravenous prostaglandin El on thrombolysis induced by human recombinant tissue-type plasminogen activator in feline peripheral arterial thrombosis. Humphrey WR: Schaub RG. Fibrinolysis Apr 1991,5 (2) p71-9 Basal expression and insulin-mediated induction of PAI- 1 mRNA in Hep*GZ cells. Grant PJ; Ruegg M; MedcaKRL. Fibrinolysis Aor 1991.5 (2) 081-6 r~A IH-NMR study of plasminogen krii le 4 interactions with intact and partially digested fibrinogen. k. ~antc M; Elliott SW, Llinas M. Fibrinolysis Apr 1991,5 (2) p87-92 Regulation of extravascular fibrinolysis by factor XIII. Uchino R Cardinali M; Chung SI. Fibrinolysis Apr 1991, 5 (2) p93-8 The effect of exogenous plasminogcn activator inhibitor-l in a canine model of occlusive thrombus formation. Reilly CF; Mayer ET; Sitko GR Hutxelmann JE; Garde11 SJ; Shebuski RJ. Fibrinolvsis Aor 1991.5 (2) o99-104 Fibrinogen l&el as’s predictor df;nortality in survivors of myocardial infarction. Cooper J; Douglas AS. Fibrinolysis Apr 1991,5 (2) ~105-8 Detection of specific forms of plasminogen activator inhibitor 1 by monoclonal antibodies. Hanano M; Chapman D; FICI ’%T Berger AE: Erickson LA; Levin EG. Fibrinolysis Apr 1991.5 (2) ~109-16 I~

Tissue plasminogen activator and lasminogen activator inhibitor in atients with liver cirrhosis. %sierraJ;AZPMJ;ViIadesE; %oblet S; Barrao P; Bayon E; Qonxakz J. Ftbrinolysis Apr 1991.5 (2) ~117-20 Silent myocardial ischaemia episodes in non-insulin dependent diabetes mellitua: relationship with haemostatic alterations. Torrado MC; Garcia Frade LJ: Lara J’E Ra o I: Cuellar L; Marin E; Garcia Avello A; de la Calk H. %tbrinolysis Apr 1991,5 (2) pl21-6 A modiied assay for blood coagulation factor XIII using enzyme immobilisatron on St hylccoccus auwus: preliminary evaluation. Whyard I C: Ablin RJ. Fibrinolysis Apr 1991.5 (2) ~127-30 Albumin, haemostasis and cardiovascular disease. Barradas MA; Mikhailidis DP: Phillios AN: Shauer AG. Fibrinolvsis , Aor n 1991,5(2)p13i ’ ’ Glycometabolic control ami fibrin01 sis in diabetic patients. van Wersch JW: Westerhuis LW; 9 enekamp WJ. Haemostasis 1990,20 (4) p241-50 Effect of disulfuam on the platelet function and fibrinolysis in healthy volunteers. Gkerup Q Bostrom S; Hansson G; TegerNilsson AC; Sjoquist PO, Winther K. Haemostasis 1990.20 (4) ~215-8 Cutaneous and plasma fibrinolytic activity in systemic sclerosis. Evidence of normal plasminogen activation. Matucci-Cerinic M; Lotti T; Lombardi A: Pignone A; Iannone F; Beneforti E ; Ciiotti S; Morfini M; Caignoni M. Int J Dermatol Nov 1990, 29 (9) ~644-8 The role of fragment X polymers in the fibrin enhancement of tissue plasminogcn activator-catalyxed plasmin formation. Suenson E; Bjerrum P; Holm A; Lind B; Meldal M; Selmer J: Petersen LC. J Biol Chem Dee 25 1990,265 (36) ~22228-37 Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerulsr epithehal cells. He CJ; Ron&au E; MedcalfRL; Lacave R Schleuning WD; Sraer JD. J Cell Physiol Jan 1991,146 (l)p13140 Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease. van Wersch Jw; Ho&en P; Rijken J. J Clin Chem Clin Biochem Aug 1990.28 (8) p5 13-7 Fibrinolysis, thrombocytopenia, and coa ulation abnormalities complicating high-dose interleukin- I. Immunotherapy. Fleischmann JD; Shingleton WB; Gallagher C; Ratnoff OD; ChahineA. JLabClinMedJan 1991: 117(1)p76-82 Vasoactive intestinal polypeptide (VIP) strmulates fibrinolytic system in the rat. Hagiwara M; Hong0 K: Morikawa T. Jpn J Pharmacol Sep 1990,54 (1) ~86-8 Thrombin regulates components of the fibrinolytic system in human mesangial cells. Vilhunediana LM; Rondeau E; He CJ, Madcalf RL; Peraldi MN; Lacave R D&rue F, Sraer JD. Kidney Int Nov 1990,38 (5) p95661 Fibrinolytic response to standardixed venous occlusion in different age groups. Hong SY; Pyo SJ; Kim MH; Kim SK; Park IS; Oh DY; Kim SJ. Korean J Intern Med Jan 1989.4 (1) p48-53 [Studies on coagulation-fibrinolytic system in diabetic nephropathy-with reference to plasma TAT and alpha ZPIC]. Watanabe S; Ogihara T; Iyori S; Kaneshige H; Nomoto Y; Sakai H. Nippon Jinx0 Gakkai Shi Scp 1990,32 (9) p995-9 [The relationship between the hyperlipidemia and the platelet function, coagulation and fibrinolysis]. Yamaraki T, Ysmada N; Yaxaki Y. Nippon Rinsho Nov 1990.48 (11) ~2660-5 [Blood coagulation and fibrinolytic studies in patients with toxemia of pregnancy]. Okamiya H. Nippon Sanka Fujinka Gakkai Zasshi Nov 1990.42 (11) ~1557-64 [A case of Crohn’s colitis with cecal perforation and abnormalities of coagulation and fibrinolytic system]. Tsuzuki Y; Serizawa H; Miura S; Kurose I; Suematsu M; Hibi T, Ishii H, Tashiro Y: Kodaira S; Tsuchiya M. Nippon Shokakibyo Gakkai Zasshi Sep 1990,87 (9) ~1878-82 [Value of intermediate compounds in ultrafiltration depending on the type of dialysis and their effect on fibrinolytic activity]. Zawartosc zwiaxkow o sredniej masie drobinowej w uhratihracie w zalexnosci od rodzaju diahxatora i ich wpLywu na aktywnosc fibrynolityczna. PopLawski A; Mysliwiec M, So&a J. Pol Tyg Lek Sop 4-25 1989.44 (36-39) p827-9 [Role of PMN elastase in fibrinolytic activity in patients with acute romyelocytic leukemia]. Soma M; Maeda Y; Kasakura S; 5 abe H. Rinsho Ketsueki Sep 1990,31(g) ~1445-9 Coagulation-tibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism. Tohgi H; Kawashima M; Tamura K; Suzuki H. Stroke Dee 1990.21 (12) ~1663-7 me products of blood coagulation and tibrinolysis and their effect on pulmonary gas-exchan e function]. Produkty p .. gemokoaguliatsii i fibrin0 rxa r ~kh vliianie na gaxoobmennuiu

\~,r~-

B5

funktsiiu lcgkikh. Riabov OA, Pascchnik IN; Emtsov IuCl; Azizov I&l. Ter Arkh 1990,62 (7) p95-8 Unbalanced coa lation-fibrinolysis potential during Lasparaginase therapy in c8!ddren with acute lymphoblaatic leukacma. Semeraro N; Montcmurro P; Oiotdano P, Schcttini P; Santoro N; De Mattia D ; C3iordano D; Coneac M; Colucci M. Thromb I&must Aug 13 1990.64 (1) ~38-40 Coagulation. fibrin01 ic and platckt function in patients on longterm thcra y wi aspirin 300 mg or 1,200 mg daily’comparcd with place0 . Hampton KK; Ccrletti C; Loiiou LA; Bucchi P; Donati MB; Davies JA, de Oactano Q Prentice CR. Thromb Hacmost Aug 13 1990.64 (1) ~17-20 The influence of coronary angiography and angioplasty on aramctc~8of hcmostasis and fibrin01 is. Six kl: Tjon RM; L uys EM; Haas F, Ho&t&r-van Za $ A; Havcrkate F. ThrombHacmostAug 13 1990,64(l)pll3-6

Activation of coagulation and fibrinolysis during surgery, analyzed b molecular marketa. Kambayashi J; Sakon M; Yokota M; SL ba E; Kawasaki T; Mori T. Thromb Rcr Ott 15 1990,60 (2) plS7-67 Fluctuation of tPA and PAL1 antigen levels in 1-p: difference of their fluctuation patbzrnabetween mak MC!fcmak.. UranoT; Sumiyoshi K; Nakamura M, Mori T; Takada Y; Taktxla A. Thromb Rea Ckt 15 1990.60 (2) pl33-9 [Effects of blood coagulating and fibrmolytic activity of tumor on the state of systemic hemostasis in patients with stomach cancer]. Vliianie mokoaguliataionnoi i fibrinolitic~skoi aktivnosti opukboE t na sostoianie sistcmnogo gemustaza u bol’nykh rakom zhcludka. Zyrianov BN; Karpuv AB; Udut W; Tsisik RM; Tikhonov VI: Tiutrin II. Vopr Onkol1990.36 (11) ~1316.21

Bibliography preparedfrom MEDLINE by the British LibraryMedical Information Service, covering the March to May 1991 files.